文献速递头颈部肿瘤放疗放疗物理与技术

重复FMISO-PET显像与局部晚期头颈鳞癌原发放化疗中缺氧相关基因表达的相关性较弱

Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.
PubMed 文献 · Radiother Oncol · 2019-03-09

研究纳入50例接受原发放化疗的局部晚期头颈鳞状细胞癌(HNSCC)患者,在治疗前及治疗中四个时间点行FMISO-PET/CT,其中42例以nanoString技术检测治疗前活检的58个缺氧相关基因表达,分析影像参数与基因表达的相关性及两者对局部区域肿瘤控制(LRC)和总生存(OS)的预后价值。结果显示FMISO-PET参数与缺氧相关基因表达的相关性较弱(ρ≤0.43),与肿瘤体积呈中等相关(ρ≤0.69),将缺氧分类器加入基于FMISO-PET参数的预后模型未能改善LRC和OS预测。作者认为FMISO-PET患者分层能力更优,可能更适合作为局部晚期HNSCC原发放化疗的分层生物标志物。

要点

  • FMISO-PET参数与缺氧相关基因表达中位水平相关性较弱,ρ≤0.43
  • 治疗第1、2周后影像与基因表达相关性较高(p<0.001)
  • FMISO-PET与肿瘤体积呈中等相关,ρ≤0.69

核心结论

  • FMISO-PET参数与缺氧相关基因表达之间相关性较低。
  • FMISO-PET显示出更优的患者分层能力,作者认为其可能优于缺氧相关基因,作为局部晚期HNSCC原发放化疗的分层生物标志物。

研究设计与样本

  • 研究纳入50例接受原发放化疗的局部晚期HNSCC患者,在治疗前及治疗中四个时间点行FMISO-PET/CT显像。
  • 其中42例患者基于任何治疗前获取的活检组织,采用nanoString技术评估缺氧相关基因表达。

主要发现

  • 缺氧相关基因中位表达与FMISO-PET测量的缺氧相关性较弱(ρ≤0.43),治疗第1周和第2周后与影像的相关性更高(p<0.001)。
  • FMISO-PET显像与肿瘤体积之间呈中等相关(ρ≤0.69)。
  • 将缺氧分类器纳入基于FMISO-PET参数的预后模型,未能改善对LRC和OS的预测。

关键数值与推荐

  • 采用Spearman相关系数ρ分析FMISO-PET参数(肿瘤-本底比和缺氧体积)与58个缺氧相关基因表达的相关性。
  • 三种缺氧相关基因特征以其表达中位数与FMISO-PET参数进行相关性比较。
  • 采用Cox回归评估两种缺氧测量方法对LRC和OS的影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypoxia is an important factor of tumour resistance to radiotherapy, chemotherapy and potentially immunotherapy. It can be measured e.g. by positron emission tomography (PET) imaging or hypoxia-associated gene expressions from tumour biopsies. Here we correlate [18F]fluoromisonidazole (FMISO)-PET/CT imaging with hypoxia-associated gene expressions on a cohort of 50 head and neck squamous cell carcinoma (HNSCC) patients and compare their prognostic value for response to radiochemotherapy (RCTx). METHODS: FMISO-PET/CT images of 50 HNSCC patients were acquired at four time-points before and during RCTx. For 42 of these patients, hypoxia-associated gene expressions were evaluated by nanoString technology based on a biopsy obtained before any treatment. The FMISO-PET parameters tumour-to-background ratio and hypoxic volume were correlated to the expressions of 58 hypoxia-associated genes using the Spearman correlation coefficient ρ. Three hypoxia-associated gene signatures were compared regarding their correlation with the FMISO-PET parameters using their median expression. In addition, the correlation with tumour volume was analysed. The impact of both hypoxia measurement methods on loco-regional tumour control (LRC) and overall survival (OS) was assessed by Cox regression. RESULTS: The median expression of hypoxia-associated genes was weakly correlated to hypoxia measured by FMISO-PET imaging (ρ ≤ 0.43), with higher correlations to imaging after weeks 1 and 2 of treatment (p < 0.001). Moderate correlations were obtained between FMISO-PET imaging and tumour volume (ρ ≤ 0.69). Prognostic models for LRC and OS based on the FMISO-PET parameters could not be improved by including hypoxia classifiers. CONCLUSION: We observed low correlations between hypoxia FMISO-PET parameters and expressions of hypoxia-associated genes. Since FMISO-PET showed a superior patient stratification, it may be the preferred biomarker over hypoxia-associated genes for stratifying patients with locally advanced HNSCC treated by primary RCTx.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Löck S, Linge A, Seidlitz A, et al. Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy. Radiother Oncol. 2019. PMID: 31015169. doi:10.1016/j.radonc.2019.02.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。